Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kummer

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sitesB A Bladergroen, M C Strik, N Bovenschen, et al.
Arthritis and Rheumatism|August 1, 1992
Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseasesJ A Kummer, J J Abbink, J P de Boer, et al.
The American Journal of Pathology|January 1, 1996
Granzyme B expression in Reed-Sternberg cells of Hodgkin's diseaseJ J Oudejans, J A Kummer, M Jiwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutionsV M van Houten, M P Tabor, M W van den Brekel, et al.
Journal of Immunological Methods|July 6, 1993
Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteinsJ A Kummer, A M Kamp, M van Katwijk, et al.
Arthritis and Rheumatism|December 1, 1994
Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissueP P Tak, J A Kummer, C E Hack, et al.
British Journal of Cancer|January 1, 1997
Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesionsH J Bontkes, T D de Gruijl, J M Walboomers, et al.
Blood|December 1, 1994
Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localizationP C de Bruin, J A Kummer, P van der Valk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implicationsM P Tabor, R H Brakenhoff, V M van Houten, et al.
Osteoarthritis and Cartilage|October 15, 2013
A validated new histological classification for intervertebral disc degenerationJ P H J Rutges, R A Duit, J A Kummer, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sitesB A Bladergroen, M C Strik, N Bovenschen, et al.
Arthritis and Rheumatism|August 1, 1992
Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseasesJ A Kummer, J J Abbink, J P de Boer, et al.
The American Journal of Pathology|January 1, 1996
Granzyme B expression in Reed-Sternberg cells of Hodgkin's diseaseJ J Oudejans, J A Kummer, M Jiwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutionsV M van Houten, M P Tabor, M W van den Brekel, et al.
Journal of Immunological Methods|July 6, 1993
Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteinsJ A Kummer, A M Kamp, M van Katwijk, et al.
Arthritis and Rheumatism|December 1, 1994
Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissueP P Tak, J A Kummer, C E Hack, et al.
British Journal of Cancer|January 1, 1997
Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesionsH J Bontkes, T D de Gruijl, J M Walboomers, et al.
Blood|December 1, 1994
Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localizationP C de Bruin, J A Kummer, P van der Valk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implicationsM P Tabor, R H Brakenhoff, V M van Houten, et al.
Osteoarthritis and Cartilage|October 15, 2013
A validated new histological classification for intervertebral disc degenerationJ P H J Rutges, R A Duit, J A Kummer, et al.
Pageof 11